These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 26275482)

  • 1. PACAP as a neuroprotective factor in ischemic neuronal injuries.
    Shioda S; Nakamachi T
    Peptides; 2015 Oct; 72():202-7. PubMed ID: 26275482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pleiotropic and retinoprotective functions of PACAP.
    Shioda S; Takenoya F; Wada N; Hirabayashi T; Seki T; Nakamachi T
    Anat Sci Int; 2016 Sep; 91(4):313-24. PubMed ID: 27324639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effects of PACAP in ischemia.
    Reglodi D; Vaczy A; Rubio-Beltran E; MaassenVanDenBrink A
    J Headache Pain; 2018 Mar; 19(1):19. PubMed ID: 29500688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of PACAP on Dry Eye Symptoms, and Possible Use for Therapeutic Application.
    Shioda S; Takenoya F; Hirabayashi T; Wada N; Seki T; Nonaka N; Nakamachi T
    J Mol Neurosci; 2019 Jul; 68(3):420-426. PubMed ID: 29931503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective roles of pituitary adenylate cyclase-activating polypeptide in neurodegenerative diseases.
    Lee EH; Seo SR
    BMB Rep; 2014 Jul; 47(7):369-75. PubMed ID: 24856828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution and functional characterization of pituitary adenylate cyclase-activating polypeptide receptors in the brain of non-human primates.
    Jolivel V; Basille M; Aubert N; de Jouffrey S; Ancian P; Le Bigot JF; Noack P; Massonneau M; Fournier A; Vaudry H; Gonzalez BJ; Vaudry D
    Neuroscience; 2009 May; 160(2):434-51. PubMed ID: 19236905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pituitary adenylate cyclase-activating polypeptide (PACAP) and its receptors in the brain.
    Shioda S
    Kaibogaku Zasshi; 2000 Dec; 75(6):487-507. PubMed ID: 11197592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies to convert PACAP from a hypophysiotropic neurohormone into a neuroprotective drug.
    Bourgault S; Chatenet D; Wurtz O; Doan ND; Leprince J; Vaudry H; Fournier A; Vaudry D
    Curr Pharm Des; 2011; 17(10):1002-24. PubMed ID: 21524253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pituitary adenylate cyclase-activating polypeptide (PACAP) in the hypothalamic-pituitary-gonadal axis: a review of the literature.
    Thomas RL; Crawford NM; Grafer CM; Halvorson LM
    Reprod Sci; 2013 Aug; 20(8):857-71. PubMed ID: 23232965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals.
    Alexandre D; Anouar Y; Jegou S; Fournier A; Vaudry H
    Endocrinology; 1999 Mar; 140(3):1285-93. PubMed ID: 10067855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The presence and distribution of pituitary adenylate cyclase activating polypeptide and its receptor in the snail Helix pomatia.
    Hernádi L; Pirger Z; Kiss T; Németh J; Mark L; Kiss P; Tamas A; Lubics A; Toth G; Shioda S; Reglodi D
    Neuroscience; 2008 Aug; 155(2):387-402. PubMed ID: 18590802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pituitary adenylate cyclase-activating polypeptide induces translocation of its G-protein-coupled receptor into caveolin-enriched membrane microdomains, leading to enhanced cyclic AMP generation and neurite outgrowth in PC12 cells.
    Zhang W; Duan W; Cheung NS; Huang Z; Shao K; Li QT
    J Neurochem; 2007 Nov; 103(3):1157-67. PubMed ID: 17680996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pituitary adenylate cyclase activating polypeptide in the retina: focus on the retinoprotective effects.
    Atlasz T; Szabadfi K; Kiss P; Racz B; Gallyas F; Tamas A; Gaal V; Marton Z; Gabriel R; Reglodi D
    Ann N Y Acad Sci; 2010 Jul; 1200():128-39. PubMed ID: 20633141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery.
    Vaudry D; Falluel-Morel A; Bourgault S; Basille M; Burel D; Wurtz O; Fournier A; Chow BK; Hashimoto H; Galas L; Vaudry H
    Pharmacol Rev; 2009 Sep; 61(3):283-357. PubMed ID: 19805477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular, cellular, and functional characterizations of pituitary adenylate cyclase-activating polypeptide and its receptors in the cerebellum of New and Old World monkeys.
    Aubert N; Basille M; Falluel-Morel A; Vaudry D; Bucharles C; Jolivel V; Fisch C; De Jouffrey S; Le Bigot JF; Fournier A; Vaudry H; Gonzalez BJ
    J Comp Neurol; 2007 Oct; 504(4):427-39. PubMed ID: 17663433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypophysiotropic action of pituitary adenylate cyclase-activating polypeptide (PACAP) in the goldfish: immunohistochemical demonstration of PACAP in the pituitary, PACAP stimulation of growth hormone release from pituitary cells, and molecular cloning of pituitary type I PACAP receptor.
    Wong AO; Leung MY; Shea WL; Tse LY; Chang JP; Chow BK
    Endocrinology; 1998 Aug; 139(8):3465-79. PubMed ID: 9681497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pituitary adenylate cyclase activating polypeptide prevents apoptosis in cultured cerebellar granule neurons.
    Cavallaro S; Copani A; D'Agata V; Musco S; Petralia S; Ventra C; Stivala F; Travali S; Canonico PL
    Mol Pharmacol; 1996 Jul; 50(1):60-6. PubMed ID: 8700120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors: distribution and involvement in the secretion of Podarcis sicula adrenal gland.
    Valiante S; Prisco M; Sciarrillo R; De Falco M; Capaldo A; Gay F; Andreuccetti P; Laforgia V; Varano L
    J Endocrinol; 2008 Feb; 196(2):291-303. PubMed ID: 18252952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurotrophic and neuroprotective effects of pituitary adenylate cyclase-activating polypeptide (PACAP) on mesencephalic dopaminergic neurons.
    Takei N; Skoglösa Y; Lindholm D
    J Neurosci Res; 1998 Dec; 54(5):698-706. PubMed ID: 9843161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of vasoactive intestinal peptide, pituitary adenylate cyclase-activating peptide, nitric oxide synthase, and their receptors in human and rat sphenopalatine ganglion.
    Csati A; Tajti J; Kuris A; Tuka B; Edvinsson L; Warfvinge K
    Neuroscience; 2012 Jan; 202():158-68. PubMed ID: 22108610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.